Search Results
You are looking at 1 - 5 of 5 items for
- Author: R Teja x
- Refine by access: All content x
Search for other papers by J. P. Hinson in
Google Scholar
PubMed
Search for other papers by G. P. Vinson in
Google Scholar
PubMed
Search for other papers by S. Kapas in
Google Scholar
PubMed
Search for other papers by R. Teja in
Google Scholar
PubMed
ABSTRACT
The rate of blood flow through the intact adrenal gland is closely linked to steroid hormone secretion, and although the mechanism involved is unknown, it is thought to involve secretory products of the vascular endothelium.
In dispersed cell preparations, endothelin-1 and -3 both caused a dose-dependent and highly sensitive increase in steroid secretion by zona glomerulosa and zona fasciculata cells of the rat and human adrenal cortex. In addition, when the perfused rat adrenal was stimulated with ACTH, significant increases in steroid secretion and perfusion medium flow rate were accompanied by significantly increased secretion of immunoreactive endothelin into the adrenal vein. It is proposed that endothelin has a role in mediating the adrenocortical response to ACTH stimulation.
Journal of Endocrinology (1991) 128, 275–280
Search for other papers by GP Vinson in
Google Scholar
PubMed
Search for other papers by R Teja in
Google Scholar
PubMed
Search for other papers by MM Ho in
Google Scholar
PubMed
Search for other papers by JP Hinson in
Google Scholar
PubMed
Search for other papers by Puddefoot JR in
Google Scholar
PubMed
The tissue renin-angiotensin systems (RAS) may have specific roles that complement those of the systemic RAS. In the adrenal, the tissue RAS has been implicated in the regulation of glomerulosa tissue growth and function, and in mediating the response of the tissue to stimulation by ACTH and potassium ions. To examine the role of the rat adrenal tissue RAS in its response to angiotensin II stimulation, adrenals were incubated either as bisected glands or as separated capsular glands (largely glomerulosa) under control conditions, or in the presence of the angiotensin-converting enzyme inhibitor captopril, or of angiotensin II, or both. Captopril inhibited the two different tissue preparations in different ways. In the capsular gland it inhibited basal aldosterone output, but facilitated its response to angiotensin II. In the bisected gland, captopril inhibited the response of aldosterone to angiotensin II. Other data suggest that one way in which captopril functions is by preventing the conversion of fasciculata-generated 18-hydroxydeoxycorticosterone (18-OH-DOC) to aldosterone in the glomerulosa. Immunolocalisation of 18-OH-DOC in perfused rat adrenal confirms that one function of angiotensin II is to mobilise tissue-sequestered 18-OH-DOC. The results illustrate the importance of tissue RAS in the synthesis of aldosterone and the response to angiotensin II.
Search for other papers by G. P. Vinson in
Google Scholar
PubMed
Search for other papers by M. M. Ho. in
Google Scholar
PubMed
Search for other papers by J.R. Puddefoot in
Google Scholar
PubMed
Search for other papers by R. Teja in
Google Scholar
PubMed
Search for other papers by S. Barker in
Google Scholar
PubMed
ABSTRACT
Little is known about the cellular localisation of the angiotensin II (AII) type 1 receptor (ATI) in the rat adrenal glomerulosa cell, but some studies have suggested that receptor internalisation and recycling may occur.
Using a specific monoclonal antibody (6313/G2) to the first extracellular domain, we show here that most of the receptor is internalised in the unstimulated cell. When viable glomerulosa cells are incubated with 6313/G2, the receptor is transiently concentrated on the cell surface, and aldosterone output is stimulated. This stimulated output is enhanced by neither threshold nor maximal stimulatory concentrations of All amide, although the antibody does not inhibit All binding to the receptor. Conversely, the stimulatory actions of the antibody and those of ACTH are additive.
The data suggest that recycling to the plasma membrane is constitutive, or regulated by unknown factors. Retention of the ATI receptor in the membrane is alone enough to allow sufficient G protein interaction to generate maximal stimulatory events.
Search for other papers by G P Vinson in
Google Scholar
PubMed
Search for other papers by R Teja in
Google Scholar
PubMed
Search for other papers by M M Ho in
Google Scholar
PubMed
Search for other papers by J R Puddefoot in
Google Scholar
PubMed
Abstract
Several lines of experimentation suggest that a tissue-sequestered pool of 18-hydroxydeoxycorticosterone (18-OH-DOC) in the rat adrenal may be mobilized as an aldosterone precursor.
We show here that this steroid is maintained in a non-extractable form in the membranes of collagenase-dispersed fasciculata/reticularis cells. Because of this stability, the complex can be identified by immunocytochemistry and also, in IEF gels of solubilized inner adrenocortical zone membrane preparations, by immunoblotting. However, the complexed steroid cannot be extracted from the gels into organic solvent unless first treated with trypsin. Preincubation of viable whole glandular tissue with trypsin significantly enhanced aldosterone output and eliminated the trypsin-releasable 18-OH-DOC pool in IEF gels of solubilized inner zone membranes. Both prior sodium depletion and acute trypsin stimulation of whole glands enhanced extractable 18-OH-DOC in glomerulosa tissue membranes.
Other experiments using in situ hybridization show that mRNA coding for 11β-hydroxylase (which generates 18-OH-DOC) is confined to the inner adrenocortical zones, whereas aldosterone synthase (which does not) is transcribed exclusively in the glomerulosa.
The data suggest that a pool of 18-OH-DOC in inner zone membranes can be mobilized for utilization as an aldosterone precursor in the glomerulosa. The results also indicate the existence of an entirely novel tightly binding steroid carrier from which steroid cannot be extracted by organic solvent unless first subjected to proteolytic degradation.
Journal of Endocrinology (1995) 144, 359–368
Search for other papers by G. P. Vinson in
Google Scholar
PubMed
Search for other papers by S. M. Laird in
Google Scholar
PubMed
Search for other papers by J. P. Hinson in
Google Scholar
PubMed
Search for other papers by R. Teja in
Google Scholar
PubMed
ABSTRACT
The time-course for the in-vitro secretion of aldosterone and 18-hydroxycorticosterone (18-OH-B) by rat adrenal whole capsular tissue (largely zona glomerulosa) was studied under control and stimulated conditions. The stimulatory effect of trypsin was relatively delayed, and the steroids were significantly enhanced only after 1 h, in contrast to the actions of ACTH, which produced effects after 15 or 30 min. Tissue-sequestered 18-hydroxydeoxycorticosterone (t-18-OH-DOC), which is not affected by ACTH, was significantly depleted by trypsin, but secreted 18-OH-DOC was not consistently affected by either stimulant. In contrast to the apparent mobilization of t-18-OH-DOC, the conversion of exogenously added [3H]18-OH-DOC to [3H]18-OH-B was inhibited by trypsin, and aldosterone was unaffected. When trilostane was added to inhibit de-novo steroidogenesis, under conditions in which the steroid secretory response to ACTH is completely inhibited, aldosterone and 18-OH-B secretion was still stimulated by trypsin although yields were lower. Compared with controls, trilostane reduced t-18-OH-DOC concentrations, and trypsin caused a further depletion.
In other studies, glomerulosa plasma membrane enriched preparations were homogenized and centrifuged, and the supernatants were dialysed and added to incubations of dispersed zona glomerulosa cells in the presence or absence of stimulators of aldosterone secretion. The addition of the supernatants, which contained high concentrations of sequestered t-18-OH-DOC, stimulated aldosterone and 18-OH-B production by collagenase-dispersed zona glomerulosa cells to a greater extent than the addition of an equivalent amount of free 18-OH-DOC or corticosterone. When trypsin, ACTH, the phorbol ester phorbol myristate acetate or increased potassium were also added, there was a further increase in 18-OH-B production, and final recoveries of 18-OH-DOC were correspondingly decreased.
The results are consistent with the hypothesis that, because of the nature of its disposition in the glomerulosa cell, t-18-OH-DOC may be utilized as a substrate for aldosterone and 18-OH-B production. The plasma membrane location of this stored steroid pool, and the known actions of phorbol ester or trypsin stimulation, suggest that it may be mobilized by protein kinase C activation.
Journal of Endocrinology (1992) 135, 125–133
